Transcription analysis on response of swine lung to H1N1 swine influenza virus by Li, Yongtao et al.
RESEARCH ARTICLE Open Access
Transcription analysis on response of swine lung
to H1N1 swine influenza virus
Yongtao Li
1†, Hongbo Zhou
1,2†, Zhibin Wen
1, Shujuan Wu
1, Canhui Huang
2, Guangmin Jia
1, Huanchun Chen
1,2
and Meilin Jin
1,2*
Abstract
Background: As a mild, highly contagious, respiratory disease, swine influenza always damages the innate immune
systems, and increases susceptibility to secondary infections which results in considerable morbidity and mortality
in pigs. Nevertheless, the systematical host response of pigs to swine influenza virus infection remains largely
unknown. To explore it, a time-course gene expression profiling was performed for comprehensive analysis of the
global host response induced by H1N1 swine influenza virus in pigs.
Results: At the early stage of H1N1 swine virus infection, pigs were suffering mild respiratory symptoms and
pathological changes. A total of 268 porcine genes showing differential expression (DE) after inoculation were
identified to compare with the controls on day 3 post infection (PID) (Fold change ≥ 2, p < 0.05). The DE genes
were involved in many vital functional classes, mainly including signal transduction, immune response,
inflammatory response, cell adhesion and cell-cell signalling. Noticeably, the genes associated with immune and
inflammatory response showed highly overexpressed. Through the pathway analysis, the significant pathways
mainly concerned with Cell adhesion molecules, Cytokine-cytokine receptor interaction, Toll-like receptor signaling
pathway and MAPK signaling pathway, suggesting that the host took different strategies to activate these
pathways so as to prevent virus infections at the early stage. However, on PID 7, the predominant function classes
of DE genes included signal transduction, metabolism, transcription, development and transport. Furthermore, the
most significant pathways switched to PPAR signaling pathway and complement and coagulation cascades,
showing that the host might start to repair excessive tissue damage by anti-inflammatory functions. These results
on PID 7 demonstrated beneficial turnover for host to prevent excessive inflammatory damage and recover the
normal state by activating these clusters of genes.
Conclusions: This study shows how the target organ responds to H1N1 swine influenza virus infection in pigs. The
observed gene expression profile could help to screen the potential host agents for reducing the prevalence of
swine influenza virus and further understand the molecular pathogenesis associated with H1N1 infection in pigs.
Background
Swine influenza is a respiratory disease in pigs character-
ized by fever, anorexia, tachypnea, dyspnea and coughing
[1]. The causative agent, swine influenza virus (SwIV)
contains three key subtypes: H1N1, H3N2 and H1N2 cir-
culating in pigs worldwide [2-5]. In pig flocks, H1N1, as
the predominant subtype in clinical surveys or in the
NCBI Influenza resource, has been further categorized
into classical swine H1N1 virus, human-like H1N1 virus
and European avian-like H1N1 virus [6-8]. In March
2009, a novel swine-origin H1N1 influenza virus contain-
ing a unique combination of gene segments of the North
American and Eurasian SwIV lineages has continued to
circulate in humans and raised severe concerns about
pandemic developments. And the finding indicates the
significant role of H1N1-subtype SwIV in the evolution
of new viruses with pandemic potential [9].
SwIV replication is mainly restricted to epithelial cells
in the respiratory tract with the lung being the major
target organ [10]. As a short-lasting disease, swine
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any medium, provided the original work is properly cited.influenza manifests itself with an incubation period of 1-
3 days, then the recovery follows, which is limited to 6
or 7 days after infection [11]. During the acute phase of
the disease, SwIV induces an overwhelming and simulta-
neous pro-inflammatory cytokines in the lungs of
infected animals [12]. Recently, researchers have found
that after H1N1 SwIV infection, secretion of innate,
pro-inflammatory, Th1, Th2, and Th3 cytokines was
observed in infected pig lungs, which could be useful
indicator for host anti-viral response and SwIV patho-
genesis [13]. Among the cytokines, several have been
demonstrated to be related with anti-viral functions or
tissue damage at the acute stage of SwIV infection, such
as IFN-alpha [14], tumour necrosis factor-alpha [15],
interleukins [16]. As mentioned above, swine influenza
infection has the characteristics of lasting for a short
period and quick recovery, which suggests that great
number anti-viral molecules, such as IFN-stimulated
genes, may play a central role in the infection course,
although the detailed information remains to be
obtained. Moreover, cytokines are suggested to be able
to partly explain why invasive SwIV could cause severe
t i s s u ed a m a g eb yi n f l u xo fi nflammatory cells, which
makes animals more susceptible to secondary bacterial
infections. In the clinical surveillance, SwIV was a fre-
quent co-infecting agent in swine pneumonia cases [17].
In the previous studies, the experimental dual infection
in pigs with a H1N1 SwIV and other pathogens were
carried out, and the results determined the contribu-
tions of SwIV infection to the enhanced susceptibility to
secondary bacteria induced pneumonia [18,19]. To date,
investigators have mainly concentrated their attention
on the implications of swine influenza for public health.
However, it is equally worth elucidating basic viral
pathogenesis of swine influenza, for swine influenza is
one of main immunesuppressive diseases in pig flocks
and causes the serious harm to the swine industry.
Along this line, it is also indispensable to study the host
response against SwIV infection and analyze the poten-
tial pathogenesis of SwIV infection.
Moreover, virus infections are generally associated
with numerous changes in gene expression of a specific
tissue or organ that determines the fate of the ultimate
outcome of the infected host. As a high density technol-
ogy, microarray gene expression profiling has been
increasingly used to evaluate the status of gene expres-
sions of pigs after being infected by different pathogens
[20,21]. In the analysis of the gene regulation patterns,
attention has been given to genes related to the key fac-
tor in the clinical course and pathology of the disease,
particularly when the host was infected with zoonosis,
like SwIV [22].
To obtain the sufficient information on host response
of H1N1 SwIV infection in pigs, the present study
focused on the global genomic analysis of transcriptional
responses of pig lungs to H1N1 virus infection using
Agilent Porcine Oligo Microarray containing more than
42,034 transcripts. The comparison of H1N1 SwIV-
infected and mock-infected pig lungs indicated that 268
and 214 DE genes were differently expressed respec-
tively on PID 3 and PID 7 (Fold change ≥ 2, p < 0.05).
As a result, these data would enable us to better under-
stand the underlying pathogenesis of H1N1 SwIV infec-
tion in pigs.
Methods
Animals and viruses
A total of 30 piglets with high-health status were
obtained from a commercial herd and were raised in
isolated facilities. To confirm that all piglets were free of
swine influenza virus prior to challenge, Hemagglutina-
tion Inhibition Test (HI) and Enzyme-linked immuno-
sorbent assay (ELISA) were performed on all pigs’ sera
and the sera were confirmed negative for the antibodies
against H1 and H3 swine influenza viruses (unpublished
data). The influenza viruses were stored at -80°C. The
biological properties of swine influenza strains including
EID50 and TCID50 were also determined (unpublished
data). The representative of these strains, designated as
A/swine/Hubei/101/2009(H1N1) was sequenced and
submitted into the Genbank (Accession numbers:
CY083005, CY083006, CY083007, CY083008, CY083009,
CY083010, CY083011, CY083012).
Virus infection and tissue collection
All procedures for animal infection and tissue collection
were performed according to protocols approved by Bio-
logical Studies Animal Care and Use Committee in
Hubei Province, PR China. At the age of day 35, 15 pigs
were randomly allocated to the non-infected group and
another 15 to the infected group. Each piglet in the
infected group was intranasaly challenged with A/swine/
Hubei/101/2009(H1N1) strain at a dose of 10
7.0EID50 in
2 ml of phosphate buffered saline (PBS) in separate
HEPA filtered containment facilities. Each piglet of the
non-infected group was treated similarly with an identi-
cal volume of PBS as control. Clinical symptoms, includ-
ing lethargy, anorexia, coughing, hyperpnea or dyspnea,
nasal and ocular discharge, and their body temperature
were recorded daily. 7 from the infected pigs and 7
from the control pigs were respectively euthanized on
PID 3 and 7 by intravenous administration of pentobar-
bital, and their lungs were removed completely. The
percentage of the surface of each pulmonary lobe
affected by macroscopic lesions was estimated visually.
Virus isolation and H1N1 specific quantitative real-time
PCR (qRT-PCR) were performed after the pigs were
sacrificed on PID 3 and 7. Quantification was achieved
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curve of a measured copy number of a plasmid bearing
a 140 bps fragment of the NP gene, amplified by using
the following primers: 5-CACTCACCTGAT-
GATTTGGCA-3 (forward) and 5- CAGCAGCTCCA-
GATCTCCTTG-3 (reverse). Some lungs from both
groups were frozen and stored in liquid nitrogen imme-
diately after collection until RNA extraction, and the
remaining were fixed in formalin for further histopathol-
ogy evaluation.
RNA extraction, reverse transcription, RNA labelling and
cRNA hybridization Total
RNA extraction from the lungs prepared from the same
lesion, areas of localized infection (with viral mRNA
present) was performed using TRIzol by following the
standard instructions (Invitrogen, Carlsbad, CA) and a
clean-up was carried out using RNeasy columns (Qia-
gen, Valencia, CA). Both RNA integrity and concentra-
tion were evaluated by Agilent 2100 Bioanalyzer by
following the manufacturer’s instructions (Agilent Tech-
nologies, Palo Alto, CA). Reverse transcription of 2 μg
total RNA and synthesis of Cy3-labelled cRNA with one
round of amplification were carried out by a commercial
Agilent array service (Shanghaibio, China) following the
standard one-cycle protocol according to the manufac-
turer’s instructions. Transcriptional profiles were
assessed using Agilent 4 × 44 K Porcine Oligo Microar-
ray which contains more than 42,034 transcripts of pig
from the database of RefSeq, Unigene and TIGR. Hybri-
dization and scanning of the arrays were carried out
according to standard protocols using a G2565BA Scan-
ner (Agilent Technologies, Palo Alto, CA).
Expression microarray analysis and bioinformatics
Raw data and statistical analyses were performed with
Feature Extraction software. Normalization was per-
formed per chip (normalized to 50th percentile) and per
gene (normalized to the median) respectively. A statisti-
cal analysis of variance (ANOVA) model was applied to
the data and the significance was showed by accepting a
false discovery rate (FDR) of 0.05. A further cut-off
threshold was applied based on a fold change of 2.0
between infected and control pigs. Then all the DE
genes were performed for hierarchical cluster (Ver.3.0)
and TreeView (Ver.1.1.1) analyses. Genes with signifi-
cant similarities to the transcripts in nr database based
on BLASTX searches were selected for GO analysis,
performed by MAS 3.0 software which was based on
DAVID database (CapitalBio, Beijing, China) [23].
Annotation results were obtained by inputting the list of
gene symbol as identifier. The Pathway analysis was
done using the MAS 3.0 software which was based on
the Kyoto Encyclopedia of Genes and Genomes database
(KEGG) (CapitalBio, Beijing, China). The raw and pro-
cessed data discussed in this publication have been
deposited in NCBI’s Gene Expression Omnibus and are
accessible through GEO Series accession number
GSE28871.
qRT-PCR for confirmation
Microarray results were validated by qRT-PCR using
SYBR green-based detection with an ABI PRISM 7500
cycler (Applied Biosystems, Foster City, CA). Total lung
RNA (1 μg) prepared as described above was reversely
transcribed in a 20 ul reaction mixture containing 2ul
avian myeloblastosis virus (AMV) buffer, 50 pM Oli-
go18T, 0.5 mM dNTPs, 10 U RNase inhibitor and 20 U
AMV reverse transcriptase (TAKARA, Japan). All pri-
mers were designed using Primer Premier 5.0 software
based on the sequences of the corresponding porcine
mRNAs in GenBank (Additional file 1). The GAPDH
gene was used for expression normalization, using the
primers described previously [23]. PCRs were triplicated
to guarantee the reproducibility of amplification of the
lung cDNA sample from each animal. Changes in gene
expression revealed by qRT-PCR were calculated by fol-
lowing the t-test reported previously [24], and a P-value
< 0.05 was considered significant. Reaction specificity
was ascertained by performing the Melt procedure at
the end of the amplification protocol; and the efficiency
of the PCR reaction was 92-99% for all reactions (slope
standard line between-3.3 and-3.6) according to the
manufacturer’s instructions (Applied Biosystems, Foster
City, CA).
Results
Clinical and Pathological evaluation
By monitoring the clinical signs of all pigs, it was intri-
guing to find that most infected pigs just showed mild
signs, such as coughing, nasal discharge and dyspnea on
PID 1-3 and recovered on PID 5-7. The average body
temperature of infected pigs started to increase on PID
1, peaked around PID 3 with 40.8°C, and returned to
the initial temperature (about 39°C) until PID 5 (P < 0.
05). As expected, the temperature of the six PBS-mock
infected pigs rose slightly on PID 1 and kept stable all
the remaining days. To investigate pathological damage
to lungs of infected pigs, 7 from the infected pigs and 7
from the control pigs were respectively euthanized on
PID 3 and 7 by intravenous administration of pentobar-
bital, and the macroscopic lesions of lungs tissues were
estimated visually (Figure 1A). Then lungs of pigs in
each group were fixed by submerging them in 4% neu-
tral buffered formalin and embedding them in paraffin.
Three-micron sections were made before they were
stained with hematoxylin and eosin (H&E). Lung tissues
in lesion areas of PID 3 showed dominant pneumonia
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and pathological responses, such as large amount infil-
tration of inflammatory cells, alveolar wall thickening
and bleeding. The pathological changes of lung tissues
on PID 7 were investigated, they just showed slightly
alveolar wall thickening with few inflammatory cells,
and the PBS-mock infected pigs didn’t show lung lesions
(Figure 1B).
Virus isolation and confirmation
The virus could be isolated from lung tissues in all
infected pigs on PID 3 and PID 7 but could only be
found in nasal swabs of pigs before PID 3. As expected,
no virus could be isolated in the controls. To investigate
the tissue distribution of virus, samples of heart, liver,
spleen, lung, kidney, trachea, tonsil, intestine and serum
from pigs were collected on PID 3 and 7 after inocula-
tion, then detected to manifest whether any virus could
be isolated from these tissues. Results showed that in
most infected pigs, the virus could be isolated only from
the trachea and lung. No virus was isolated from heart,
liver, intestine, spleen, tonsil or kidney in any infected
pigs. The above results were confirmed by qRT-PCR
using specific primers for the NP gene (unpublished
data). Based on these results, we chose three pigs from
each group to perform the following studies.
Gene expression alterations in the lung tissue
To analyse the genomic expression of SwIV-infected
pigs, total RNA was extracted from the infected pig
lungs (with viral mRNA present) and from the control
pig lungs at the same area. The transcriptome analysis
indicated that the detection ratios of all probe sets in
the chip representing “expression transcripts” were 75-
85% in different samples, which could exactly meet the
quality control standards. The global expression profile
of porcine lungs of the infected group was compared
with that of the control group. After quantile normaliza-
tion and statistical analyses, a total of 534 and 467 tran-
scripts at acute and recovery phases were respectively
identified to be differentially expressed (Fold change ≥
2, p < 0.05). The functions of the DE genes were ana-
lysed by MAS 3.0 software. Surprisingly, about half of
the transcripts at both time points were not functionally
A
B
PID 3 PID 7
H1N1 Control
Control H1N1
(ii)    (iii) (i)
Figure 1 The macroscopic and microscopic lung lesions in pigs infected with H1N1 SwIV. (A) Pigs were PBS-mock infected or infected
with H1N1 SwIV. On PID 3 and 7, extensive areas of macroscopic lesions of lungs tissues were observed in lungs of virus-infected pigs. (B)
Hematoxylin- and eosin-stained sections of lungs from control pigs and the pigs infected with H1N1 SwIV. The microscopic lesions of lung
tissues collected on PID 3 and 7 showed acute pneumonia with pathological changes: alveolar wall thickening, bleeding, debris in the lumen,
and the accumulation of inflammatory cells, indicated by an arrow (panel ii and iii). The lungs of PBS-mock infected pigs showed normal
bronchial epithelial lining and absence of inflammatory cells (panel i).
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functional annotation on PID 3 and 214 genes on PID
7, and all DE genes were performed for hierarchical
cluster (Figure 2A and 2C). Amongst the DE genes on
PID 3, a set of 160 genes were up-regulated and the rest
of 108 genes were down-regulated. The DE genes
mainly clustered into functional groups: signal transduc-
tion (e.g. TLRs, RLRs), immune response (e.g. GBP1,
OAS2), inflammatory response (e.g. CXCL9, CXCL10),
cell adhesion (e.g. SELL, SELE), cell-cell signaling (e.g.
CCR5, TGF-b2), biological process (e.g. RETN, APO-
BEC3A), transport (e.g. Haptocorrin, AQP7), oxidation
reduction (e.g. DUOX2, ALOX15), interspecies interac-
tion between organisms (e.g. IFIH1, STAT1), response to
virus (e.g. MX1, ISG20)a n ds oo n( F i g u r e2 B ) .P a r t i c u -
larly, the genes associated with immune and inflamma-
tory response were highly overexpressed among the up-
regulated genes, which indicated that they may play
important roles in host defense response at the early
stage of infection (Table 1). Through similar analysis, on
PID 7, it was found that the predominant groups of DE
genes contained signal transduction, metabolism, tran-
scription, development and transport, however, the DE
genes related with immune and inflammatory responses
b e c a m et h em i n o r i t yi nn u m b e r( T a b l e2 ) .T h er e s u l t s
presented here reflected that it was beneficial for the
host to prevent excessive inflammatory damage and
recover the normal state by activating these clusters of
genes mentioned above (Figure 2D). When comparing
the DE genes on PID 3 and 7, only 23 genes were pre-
sent in the two time points, and they may exert a con-
tinuous impact on host at both early and recovery
stages (Additional file 2). The complete microarray data-
set of the two time points with functional annotations
and the changes at expression level is summarized in
Supplementary Table (Additional file 3).
Pathway analysis
To gain insight into the different biological processes of
swine influenza infection at the different time points, a
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Figure 2 Clustering and characterization of the differential expression of genes. (A) The DE genes showing clear functional annotation on
PID 3 have been selected for cluster analysis which is described in methods. Amongst the DE genes on PID 3, a set of 160 genes were up-
regulated and the rest of 108 genes were down-regulated. Each row represents a separate gene and each column represents a separate piglet.
Color legend is on the left, the color scale ranges from saturated green for log ratios -3.0 and above to saturated red for log ratios 3.0 and
above. Red indicates increased gene expression levels; green indicates decreased levels compared with normal samples. (B) Categories of
annotated genes based on biological process GO term. On PID 3, the DE genes mainly clustered into 34 functional groups with varied numbers.
(C) The genes showing clear functional annotation on PID 7 have been selected for cluster analysis. (D) On PID 7, the DE genes mainly clustered
into 33 functional groups with varied numbers. Many categories shared the same genes.
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Page 5 of 14Table 1 The DE genes associated with immune and inflammatory responses on PID 3
Functional
classification
Gene description Gene
symbol
Fold
Change
Gen Bank ID
CD45 antigen isoform 3 Fragment CD45 38.62459 AK230523
Sus scrofa antibacterial protein PMAP-23 21.70289 EW419136
Sus scrofa peptide antibiotic PR39 PR39 13.50724 NM_214450
immune Sus scrofa chemokine ligand 26-like mRNA CCL26 8.645769 NM_001078665
response Sus scrofa protegrin 4 NPG4, mRNA NPG4 8.237142 NM_213863
Sus scrofa immunoglobulin kappa variable group IGKV 6.440473 CB286369
Sus scrofa 2’-5’-oligoadenylate synthetase-like mRNA OASL 5.803129 NM_001031790
Interferon-stimulated gene 20 kDa protein ISG20 5.414398 NM_001005351.2
Sus scrofa chemokine C-X-C motif ligand 10 mRNA CXCL10 5.329808 NM_001008691
Rep: IL-1 receptor 2-Bos taurus Bovine, partial 98% IL1R2 5.321422 NM_001046210.1
Sus scrofa MHC class II histocompatibility antigen SLA-DQA1 5.232868 AK230483
Sus scrofa cathepsin L1-like CTSL1 4.814094 AK230898
Sus scrofa interferon regulatory factor 3 (IRF3), mRNA IRF3 4.320395 NM_213770
Sus scrofa Fc fragment of IgG, low affinity IIb, receptor, mRNA FCGR2B 3.622257 NM_001033013
Sus scrofa CD14 molecule, mRNA CD14 3.544918 NM_001097445
Sus scrofa interferon stimulated gene 15 mRNA ISG15 3.45 EU584557.1
Sus scrofa IgG heavy chain LOC396781, mRNA IgG 3.438582 NM_213828
Sus scrofa interferon-induced protein with tetratricopeptide repeats 1 IFI56 3.386147 XM_001928724
Sus scrofa inducible T-cell co-stimulator ICOS, mRNA ICOS 3.353116 NM_001044546
Sus scrofa interferon regulatory factor 7 IRF7, mRNA IRF7 3.249327 NM_001097428
Sus scrofa myxovirus influenza virus resistance 1, interferon-inducible protein p78
MX1, mRNA
MX1 3.237013 NM_214061
Sus scrofa MHC class I antigen SLA-2 3.187732 AK231553
Sus scrofa cytotoxic T-lymphocyte-associated protein 4 CTLA4, mRNA CTLA4 3.184663 NM_214149
Sus scrofa DEAD Asp-Glu-Ala-Asp box polypeptide 58 DDX58, mRNA DDX58 3.122048 NM_213804
Rep:Tumor necrosis factor receptor superfamily member 17-Homo sapiens TNFRSF17 3.071191 NM_001192.2
Sus scrofa CD8a molecule CD8A, mRNA CD8A 2.834259 NM_001001907
Similar to melanoma cell adhesion molecule CD146 -2.819245 BX915975
similar to guanylate binding protein 4 GBP4 2.780124 AK239735
Sus scrofa guanylate binding protein 1, interferon-inducible, 67 kDa GBP1, mRNA GBP1 2.765026 NM_001128473
Sus scrofa ubiquitin specific peptidase 18, mRNA USP18 2.732302 NM_213826
Sus scrofa interferon-induced protein with tetratricopeptide repeats 2 mRNA IFI54 2.729199 AK230663
mast cell immunoreceptor signal transducer-like CLNK 2.704822 AK237804
Rep:CD274 molecule CD274, mRNA- Homo sapiens CD274 2.648947 EW655654
Sus scrofa CD163 molecule CD163, mRNA CD163 2.633336 NM_213976
Sus scrofa interferon-induced protein 44 mRNA IFI44 2.629777 AK233687
Sus scrofa interleukin 12A natural killer cell stimulatory factor 1, IL12A, mRNA IL12A 2.580563 NM_213993
Sus scrofa guanylate binding protein 2, interferon-inducible GBP2, mRNA GBP2 2.561492 NM_001128474
Sus scrofa interferon-induced protein with tetratricopeptide repeats 3, mRNA IFI60 2.465327 XM_001928703
Sus scrofa interferon-induced transmembrane protein 1 IFITM1 2.407903 AK237820
Sus scrofa chemokine C-C motif receptor 5, mRNA CCR5 2.374719 NM_001001618
Sus scrofa chemokine C-C motif receptor 10, mRNA CCR10 2.36215 NM_001044563
Sus scrofa chemokine C-C motif ligand 28, mRNA CCL28 2.330211 NM_001024695
Sus scrofa chemokine C-X-C motif ligand 9 mRNA CXCL9 2.312722 BP169836
Sus scrofa transporter 1, ATP-binding cassette, sub-family B MDR/TAP TAP1, mRNA TAP1 2.15635 NM_001044581
Sus scrofa Fas ligand TNF superfamily, member 6, mRNA FAS 2.098484 NM_213806
Sus scrofa immunoglobulin-associated alpha CD79A, mRNA CD79A 2.086904 NM_001135962
Sus scrofa interferon induced with helicase C domain 1 IFIH1, mRNA IFIH1 2.075703 NM_001100194
Sus scrofa aquaporin 9, mRNA AQP9 2.067154 NM_001112684
Sus scrofa tumor necrosis factor superfamily member 18 mRNA, partial cds TNFSF18 2.065184 DQ995649
Sus scrofa 2’-5’-oligoadenylate synthetase 2, 69/71kDa OAS2, mRNA OAS2 2.054377 NM_001031796
Li et al. BMC Genomics 2011, 12:398
http://www.biomedcentral.com/1471-2164/12/398
Page 6 of 14pathway analysis was performed on DE genes. We
selected most genes for further examination, based on
their potential implication in immune and inflammatory
response processes. On PID 3, by using the KEGG data-
base, the significant pathways mainly contained Cell
adhesion molecules, Cytokine-cytokine receptor interac-
tion, Toll-like receptor signaling pathway and MAPK
signaling pathway, which suggested that at the early
stage, the host took different strategies to activate
immune and inflammatory response so as to prevent
from virus infections. However, on PID 7, PPAR signal-
ing pathway and Complement and coagulation cascades
became the most significant pathways, indicating that
t h eh o s ts t a r tt or e p a i re x c e s s i v et i s s u ed a m a g eb ya n t i -
inflammatory functions at the recovery stage (Table 3).
Validation of microarray data by qRT-PCR
In order to get an overall validation of the microarray
results, 13 genes with different levels of altered expres-
sion (10 up-regulated and 3 down-regulated) were
selected for qRT-PCR confirmation, based on their
involvement in different functional groups or pathways.
Results showed that the altered expression of these 13
genes identified by microarray was consistent with the
results of qRT-PCR (Figure 3), although the extent of
the changes as measured by the two methods did not
match exactly due to the different nature of the proce-
dures (Table 4). What’s more, qRT-PCR of 15 represen-
tative genes associated with anti-viral immune function
were performed including TLRs and interferon-induced
genes (ISGs) and found the similar tendency as microar-
ray results (Table 5). The data could indicate that the
results from the microarray analysis are good indicators
of overall changes in gene expression.
Discussion
Swine influenza is an acute respiratory disease caused by
influenza A viruses that circulate among pigs with few
or no clinical signs. However, after swine influenza
infection, the altering host response predisposes to sec-
ondary bacterial infection in pigs through complicated
mechanisms. At present, the molecular mechanisms of
Table 1 The DE genes associated with immune and inflammatory responses on PID 3 (Continued)
similar to cystatin F CST7 2.042642 CJ009409
Sus scrofa Ig gamma 2b chain constant region IGG2B 2.017483 AK237225
Sus scrofa CD86 molecule CD86, mRNA CD86 2.007655 NM_214222
Sus scrofa vitronectin VTN, mRNA VTN -2.006228 NM_214104
Sus scrofa chemokine ligand 26-like protein LOC780409, mRNA CCL26 8.645769 NM_001078665
Sus scrofa Toll-like receptor 3 TLR3 7.331916 NM_001097444.1
Sus scrofa chemokine C-X-C motif ligand 10, mRNA CXCL10 5.329808 NM_001008691
Sus scrofa selectin L (SELL), mRNA SELL 4.497706 NM_001112678
inflammatory Sus scrofa inflammatory response protein 6, mRNA IRG6 3.840661 NM_213817
response Sus scrofa C1q-related factor LOC780424, mRNA CRF 3.627351 NM_001078676
Sus scrofa CD14 molecule CD14, mRNA CD14 3.544918 NM_001097445
Sus scrofa alpha-1-antichymotrypsin 2 SERPINA3-2 SERPINA3 3.119463 NM_213787
Sus scrofa complement C4 C4, mRNA C4 2.949702 NM_001123089
Sus scrofa selectin E SELE, mRNA SELE -2.879741 NM_214268
Sus scrofa toll-like receptor 2 (TLR2), mRNA TLR2 2.8723 NM_213761
Similar to melanoma cell adhesion molecule CD146 -2.819245 BX915975
Sus scrofa toll-like receptor 8 TLR8, mRNA TLR8 2.675719 NM_214187
Sus scrofa CD163 molecule CD163, mRNA CD163 2.633336 NM_213976
Rep: transforming growth factor, beta 2- Macaca mulatta TGFB2 -2.554227 EV858461
Sus scrofa chemokine C-C motif receptor 5, mRNA CCR5 2.374719 NM_001001618
Sus scrofa chemokine C-C motif ligand 28, mRNA CCL28 2.330211 NM_001024695
Sus scrofa chemokine C-X-C motif ligand 9 CXCL9 2.312722 BP169836
Sus scrofa serpin peptidase inhibitor, clade E member 1 SERPINE1, mRNA SERPINE1 2.225002 NM_213910
Sus scrofa Toll-like receptor 9 TLR9, mRNA TLR9 2.200666 NM_213958
Rep: arachidonate 15-lipoxygenase Alox15 gene- Mus musculus Alox15 -2.168114 AK238353
Sus scrofa signal transducer and activator of transcription 1 STAT1, mRNA STAT1 2.116864 NM_213769
Sus scrofa S100 calcium binding protein A2 S100A2 2.04835 XM_001929556
Sus scrofa serpin peptidase inhibitor, clade G1 inhibitor, member 1 SERPING1, mRNA SERPING1 2.022489 NM_001123194
The DE genes associated with immune and inflammatory responses were assigned based on GO term and manual annotation. Manual annotations were listed in
italics. Most genes could also be classified into other categories but only immune and inflammatory responses were considered.
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Page 7 of 14host factors involved in pathogenesis and secondary
infection have not been clearly established due to the
lack of overall information about host response after
influenza infection in pigs. The pathogenesis of swine
influenza resembles that of human influenza [25]. In
humans, many studies have shown that the severe dis-
ease associated with influenza infection might arise
through different mechanisms, and one important factor
is the augmented host response induced by influenza
virus [25]. In view of this, a genomic expression analysis
was performed to obtain global information of the host
response in lungs of infected pigs at different infection
stages. While our clinical and pathological findings are
in keeping with the findings of other authors, our
Table 2 The DE genes associated with immune and inflammatory responses on PID 7
Functional
classification
Gene description Gene symbol Fold Change Gen Bank ID
Rep:CD274 molecule CD274, mRNA- Homo sapiens CD274 2.648947 EW655654
immune Sus scrofa complement component C6 C6 2.660923 NM_001097449
response Sus scrofa lymphocyte cytosolic protein 2 LCP2 2.461111 AK230876
Rep:Sus scrofa tumor necrosis factor superfamily member 18 mRNA TNFSF18 2.5221772 DQ995649
Sus scrofa interleukin 2 receptor, alpha IL2RA 3.3108058 NM_213835
Sus scrofa C-type lectin domain family 5, member A CLEC5A 4.702034 NM_213990
Sus scrofa interferon stimulited exonuclease gene 20 kDa ISG20 2.1768405 NM_001005351
Sus scrofa MHC class II DR-alpha (SLA-DRA) SLA-DRA 2.0392556 NM_001113706.1
Sus scrofa secreted phosphoprotein 1 SPP1 3.411632 NM_214023
Sus scrofa lymphocyte-activation gene 3 LAG3 2.0111256 NM_001105306
Sus scrofa selectin E SELE 9.232597 NM_214268
Sus scrofa chemokine ligand 26-like mRNA CCL26 8.645769 NM_001078665
Sus scrofa Toll-like receptor 3 TLR3 7.331916 NM_001097444.1
Sus scrofa matrix metallopeptidase 25 MMP25 3.32788 NM_213905
Sus scrofa toll-like receptor 7 TLR7 3.262197 NM_001097434
inflammatory response Sus scrofa interleukin 13 IL13 2.4685268 NM_213803
Sus scrofa sphingosine 1-phosphate receptor 3-like S1PR3 2.293045 BP173206
chemokine (C-C motif) ligand 8 CCL8 2.0915823 NM_001164515.1
Sus scrofa S100 calcium binding protein A2 S100A2 2.04835 XM_001929556
Sus scrofa Toll-like receptor 5 TLR5 - 2.10299 NM_001123202
Rep: transforming growth factor, beta 2- Macaca mulatta TGFB2 - 2.180843 EV858461
Rep: leukocyte cell-derived chemotaxin 2 LECT2 - 2.381497 NM_002302.2
Sus scrofa S100 calcium binding protein A16 S100A16 - 13.31639 NM_001190208.1
The DE genes associated with inflammatory response were assigned based on GO term and manual annotation. Manual annotations were listed in italics. Most
genes could also be classified into other categories but only immune and inflammatory responses were considered.
Table 3 The key pathways that contain an over-representation of regulated genes in pig lungs after incubation with
H1N1 SwIV on PID 3 and 7
KEGG pathway(PID 3) Gene number KEGG pathway(PID 7) Gene number
Cell adhesion molecules (CAMs) 17 PPAR signaling pathway 8
Cytokine-cytokine receptor interaction 15 Focal adhesion 8
Toll-like receptor signaling pathway 13 Cytokine-cytokine receptor interaction 8
MAPK signaling pathway 13 Complement and coagulation cascades 7
Focal adhesion 12 Wnt signaling pathway 6
Complement and coagulation cascades 10 Adherens junction 4
T cell receptor signaling pathway 8 ECM-receptor interaction 4
Antigen processing and presentation 7 Toll-like receptor signaling pathway 4
PPAR signaling pathway 5 Cell cycle 4
ECM-receptor interaction 5 Cell adhesion molecules (CAMs) 4
Jak-STAT signaling pathway 4 Natural killer cell mediated cytotoxicity 4
B cell receptor signaling pathway 4 Oxidative phosphorylation 4
At each time-point, the pathway classes were more than the results present in the table. Only these containing relative high gene numbers and low p-Value
were chose for analysis.
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Page 8 of 14unique immunological data allows for the ability to
explain the short-lasting clinical signs and severe patho-
logical changes over the course of illness through
immune and inflammatory responses of pigs to H1N1
SwIV.
Anti-viral innate immune response
The innate immune system functions as the first line of
host defense against numerous pathogens. Pattern
recognition receptors (PRRs) are a class of innate
immune response expressed sensors that provide the
host with the ability to detect and respond to virus
infection, then trigger a class of anti-viral signaling cas-
cades, ultimately ensuring production of necessary effec-
tors molecules required for virus elimination, such as
type-I interferons (IFNs). In this study, we found that
several pattern recognition receptors were over-
expressed in the infected pigs on PID 3, including intra-
cellular sensors (MDA5, RIG-I and TLR3,8,9) and extra-
cellular sensors (CD14 and TLR2) with differently
increased folds, which was determined by qRT-PCR.
With this in mind, we hypothesized that Toll-like recep-
tors (TLRs) and RIG-I like receptors (RLRs) might be
activated by SwIV then the receptors triggered the acti-
vation of NF-B and IRF3/7, which cooperated in induc-
tion of antiviral type I IFNs [26]. Different TLR family
detects distinct microbial pathogen associated molecular
patterns (PAMPs) and triggers the activation of specific
signaling pathways, leading to induction of interferons
[27]. Though interferons were not observed up-regu-
lated on PID 3, we hypothesized that interferons might
be induced at the earlier time of infection, which could
be indicated by the following enhanced production of
ISGs [28]. ISGs are a large family of IFN-signaling and
IFN-stimulated immune mediators, which may have a
crucial role in antiviral response and host defense
[29,30]. The present study found that on PID 3, ISGs
particularly showed the increase of the expression to a
relatively high level in response to H1N1 virus infection
in pigs, and many showed even higher level, e.g. OASL,
O A S 2 ,M X 1 ,I R F 7 ,I R F 3 ,I F I T 1 ,I F I T 2 ,I F I T 3 ,I S G 1 5 ,
ISG20 and ISG44. Several recent microarray results have
also highlighted the common involvement of IFN-
mediated anti-viral responses in the acute phase of
influenza infections in other animal models, and illu-
strated the role of interferons in the first line of defense
against virus infections [31]. In addition, there are sev-
eral functionally less well characterized interferon-
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Figure 3 Validation of the microarray data by qRT-PCR
analyses. The genes of TAP1, SAA2, C4, CD2, IRG6, TCN1, ISG20, PR39,
PMAP23 and NPG4 were up regulated in SwIV infected pigs
compared with normal controls; TGFB2, VEGFA, TLR5 were down
regulated. Fold change is calculated based on the mean intensity
value from 3 pigs by using the comparative Ct method. Significant
levels were analyzed by T-test.
Table 4 An overall validation of microarray data by qRT-
PCR
Gene GenBank ID Microarray FC qRT-PCR FC
TAP1 NM_001044581 2.46 2.83
SAA2 CB475095 8.42 2.86
C4 CF366280 2.95 3.53
CD2 NM_213776.1 2.93 6.43
IRG6 NM_213817.1 3.84 32.50
TCN1 BX675338 7.37 3.56
ISG20 NM_001005351.1 5.41 2.15
PR39 NM_214450 13.51 16.48
PMAP23 EW419136 21.7 13.07
NPG4 NM_213863 8.24 21.99
TGFB2 NM_214015.1 -2.55 -3.83
VEGFA EU714324 -2.42 -6.20
TLR5 NM_001123202 -2.10 -5.78
Fold changes of gene expression in the porcine lung 3 days following H1N1
SwIV infection compared with the controls. The fold changes were calculated
by the formula of 2
-delta-delta Ct, data was means ± SD of triplicate reactions for
each gene transcript. The expression level of GAPDH was assayed for
normalization during quantitative PCR.
Table 5 A validation of Toll-like receptors and IFN-
stimulated genes by qRT-PCR
Gene GenBank ID Microarray FC qRT-PCR FC
TLR2 NM_213761.1 2.87 4.61
TLR3 NM_001097444.1 7.33 3.42
TLR8 NM_214187 2.68 2.44
TLR9 NM_213958 2.20 1.64
IRF3 NM_213770.1 4.32 6.33
IRF7 NM_001097428 3.25 11.1
Mx1 NM_214061 3.24 10.36
ISG15 EU584557.1 3.45 5.21
ISG20 NM_001005351.1 5.41 2.15
ISG54 XM_001928671.2 2.73 6.27
ISG56 XM_001928724; 3.39 3.43
ISG60 XM_001928703 2.47 5.70
GBP1 NM_001128473 2.78 12.0
OASL NM_001031790 5.80 2.05
OAS2 NM_001031796 2.05 28.80
qRT-PCR results of 4 Toll-like receptors and 11 IFN-stimulated genes in the
SwIV -infected pigs compared with the controls. Gene expression is depicted
as relative expression compared to GAPDH gene expression.
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Page 9 of 14induced genes, such as INDO, CXCL9, CXCL10, GBP1,
GBP2, GBP4, IFITM1 and CD274. CD274 is up-regu-
lated on lymphocytes upon IFN-gamma activation and
plays a role in T cell co-stimulation and apoptosis dur-
ing viral infections [32]. GBPs belong to the same
families of IFN inducible GTPases as Mx1, and human
GBP1 and GBP2 have been implicated in the resistance
to VSV and ECMV infection [33]. The role of porcine
GBPs in the influenza virus replication is in process of
our research, but the experiment results achieved so far
could imply that GBP1 has a significant anti-viral effect
for influenza (unpublished data). The interferon-induci-
ble transmembrane proteins (IFITMs) have recently
been discovered to restrict an early replication of influ-
enza A virus and flaviviruses, including dengue virus
and West Nile virus [34]. The up-regulation of IFN-
inducible genes after virus infection suggests that the
expressions of these genes may play important roles in
host antiviral activities. To further confirm the overre-
presentation of antiviral genes, qRT-PCR of 15
representative genes was performed including TLRs and
ISGs and the similar tendency as microarray results was
observed (Figure 4). It was interesting to note that
although the majority of up-regulated genes involved in
the anti-viral immune response, three inhibitory genes
were also up-regulated, including ISG15, USP18 and
ISG56, which had been reported as the negative regula-
tors of the RLRs signaling or IFN signaling [35-37]. This
finding indicated that the production of these negative-
regulated genes was an equally important factor of the
host response which may keep extremely pulmonary
response in check and help restore the host to its nor-
mal state when the infection is no longer present.
IFNs also stimulate the production of the MHC class I
and II proteins which play important roles in the
immune response to infections. In humans, HLA-B
(major histocompatibility complex (MHC); class I; B)
and HLA-DRB1 (MHC; class II; DR beta 1) are involved
in antigen presentation and the connection of the innate
immune system with the adaptive immune system. In
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IRF7             Sus scrofa  interferon regulatory factor 7
Mx1              Sus scrofa  myxovirus influenza virus resistance  1 
ISG15           Sus scrofa  interferon stimulated gene 15 
ISG20           Sus scrofa interferon stimulated gene 20
ISG54           Sus scrofa interferon stimulated gene 54
ISG56           Sus scrofa interferon stimulated gene 56
ISG60           Sus scrofa interferon stimulated gene 60
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Figure 4 The validation of Toll-like receptors and IFN-stimulated genes by qRT-PCR analyses. (A) The genes in this bioset [differentially
regulated by 2-fold or more (P < 0.05)] were clustered according to a hierarchical algorithm; red bars represent up-regulated levels of the 15
representative genes after H1N1 infection, including TLRs and interferon-induced genes (ISGs) which were involved in anti-viral signal molecular
or effectors. (B) The genes of TLRs and interferon-induced genes (ISGs) were up-regulated at various degrees in H1N1 SwIV infected pigs
compared with the normal controls.
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Page 10 of 14the present study, interestingly, both of the MHC genes,
SLA-B and SLA-DQA were up-regulated, at 3.2-fold and
5.2-fold respectively. Previous studies have demonstrated
that viruses have evolved mechanisms to inhibit MHC
class I expression by interfering with the function of the
MHC class I assembly machinery in the endoplasmic
reticulum and by exploiting endoplasmic-reticulum-
associated degradation pathways [38]. Different influenza
strains demonstrate various abilities in modulating the
mRNA expression of MHC class. On the one hand,
H3N2 influenza virus could cause the up-regulation of
MHC class I mRNA expression levels [39]. On the other
hand, the expression of MHC class I did not increase
due to the infection of macrophages with a low patho-
genic H7N2 AIV [40]. Thus, it can be suggested that
H 1 N 1S w I Vm a yb eu n a b l et oi n h i b i tM H Cg e n e s
expression, which should be an important host factor
for easily controlling virus.
Besides the above anti-viral agents, another important
defense component of an animal innate immune
response is constitutive or inducible production of anti-
microbial host defense peptides (HDPs). Besides MAPK
and JAK/STAT signaling pathways, interaction between
virus and TLRs can trigger the NF-B transcription fac-
tor, thus activating down-stream signaling pathway
responsible for producing HDPs [41]. In this study, we
detected several high-expression antimicrobial peptides
o nP I D3 ,s u c ha sPMAP23, PR39, CAMP and NPG4
which were all up-regulated with 21.7-fold, 13.5-fold,
8.3-fold and 8.2-fold respectively. A correlation between
the acute SwIV infection and the high level of HDP pro-
duction in pig lungs was demonstrated by qRT-PCR. To
evaluate antiviral activity of the HDPs, PMAP23 and
NPG4 were chosen to further characterize the function
in vitro. The primary results demonstrated that in most
cases, either peptides pre-incubation with virus prior to
addition to cells, or simultaneous addition to cells in
cell culture medium, yielded similar results with regard
to inactivation of viral infectivity in a dose-dependent
manner (unpublished data). These findings suggest that
HDPs contribute to an early host defense against SIV
infection which may be the potential antiviral effectors
of pigs.
Inflammatory responses
When successfully overcoming the first barrier of host
defense, influenza virus will infect the lung epithelial cells
and macrophages then activates the production of pro-
inflammatory cytokines and chemokines through distinct
signaling pathways [42,43]. Using DNA microarrays, the
gene expression patterns that correlate with inflamma-
tory response of virus infection can be identified.
Through such approach, it has been reported that differ-
ent animals (such as primates, ferrets and mice) with
influenza infection have been induced extraordinarily
high expression of cytokines and chemokines (e.g.
CXCL10, CCL2 and CXCL9) [44-46]. In the current
report, we found that a large amount of genes involved in
inflammatory response were up-regulated at various
degrees after H1N1 SwIV infection, such as SERPINA3,
CXCL9, CXCL10, CD163, CD14, CCR5, CCL26, C4 and
ALOX15. Furthermore, we also found that thirteen genes
involved in Toll-like receptors pathway and another thir-
teen genes in MAPK signaling pathway were regulated,
which reflected the up-stream signaling cascades that
could lead to secretion of inflammatory cytokines and
chemokines. The role of pro-inflammatory cytokines and
chemokines in the pathogenesis of H1N1 virus infection
in mammal remains controversial. For instance, in
response to pro-inflammatory cytokines, immune cells
migrate toward the areas of infection where they exert
host defense functions by phagocytosing cell debris and
invading microorganisms, and eventually controlled the
infection. However, the overabundant productions of
inflammatory responses are responsible for the signs and
pathogenesis of influenza infection [47,48]. For example,
CXCL10 is thought to play a role in the temporal devel-
opment of innate and adaptive immunity in concert with
type I and II IFNs [49]. However, previous studies in vivo
have also shown that CXCL10 potentially contributes to
lung pathology of H1N1 virus infection [50]. In addition,
the receptors of chemokines play an important role in
site-directed migration and activation of leukocytes. In
our studies, CCR5, CCR10 and CXCR6 were slightly up-
regulated at the early infection. Previous studies have
proved that avian H1N1 influenza virus could enhance
expression of CCR5 in infected adult MDMs [51]. Using
knock-down mice model, CCR5 was demonstrated to
play a significant role in reducing the mortality rates of
mice after influenza virus infection, which indicated that
CCR5 significantly affected the course of immune
mechanisms as well as the clinical outcome, although in
a profound way [52]. In addition, it has been deeply stu-
died that cell adhesion molecules, which can mediate
virus-elicited alveolar monocyte accumulation in SwIV-
infected pigs, play essential roles in many immune and
inflammatory responses [53]. In the current study,
through KEGG pathway analysis, we found that cell
adhesion molecules (CAMs) pathway was the significant
one during the acute virus infection, which contained the
families of immunoglobulin superfamily (IGSF21), selec-
tins (SELL, SELE), and others like F 1 1 R ,C D 2 7 4 ,C D 2 ,
CR2 and their ligands. Briefly, the above results suggest
that the production of inflammatory cytokines and cell
adhesion molecules in pigs could not only contribute to
the control of virus replication but also elicit significant
tissue damage of lung in the context of acute H1N1 virus
infection.
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Page 11 of 14In order to keep homeostasis of development and
metabolism, the host must express anti-inflammatory
factors to prevent excessive inflammatory damage
caused by infection. In this study, we found several
genes were regulated after influenza infection which
involved in anti-inflammatory functions through PPAR
signaling pathway especially on PID 7. The activation of
PPAR pathway can play the significant role in anti-
inflammatory process because they reduce expression of
several pro-inflammatory cytokines, chemokines, and
cell adhesion molecules [54]. Except for genes of PPAR
signaling, we also detected up-regulation of other indivi-
dual anti-inflammatory factors, such as IL1-RA, IL2RA,
HSP40 and HSP70. Interestingly, as the anti-inflamma-
tory mediator, TGF-b2 was found to be down-regulated
for SwIV infection throughout the whole process, which
was demonstrated by qRT-PCR. Previous studies
showed that human H1N1 virus could induce a persis-
tent elevation of TGF-b2 mRNA at human pulmonary
epithelial cells [55], while highly pathogenic H5N1 virus
could cause a down-regulation of TGF-b secretion in
mice model which resulted in more severe and wide-
spread lesions [56]. Whether the down-regulation of
TGF-b was caused by swine influenza or responsible for
acute lung immunopathology of early infection of swine
influenza remains to be further studied. From these ana-
lyses, we could propose that the infection course is the
balance of pro-inflammatory versus anti-inflammatory
factors, and these in common affects clinical outcome of
influenza virus infections.
Acute-phase response
Acute phase proteins (APPs), such as LTF, SAA2 and
coagulation factor XIII, were involved in physiologic
reactions initiated early in the inflammatory process
[57]. Acute phase proteins were also reported as host
antiviral factors against virus infection. In response to
influenza virus infection, numerous acute phase proteins
in plasma, such as CRP, SAA1,a n dOrosomucoid,
increased dramatically in concentration [58,59]. In the
present study, we found several genes such as SER-
PINA3, MBL2, F2, CD163, SAA2 and lactotransferrin
were all up-regulated with 3.12-fold, 2.57-fold, 2.14-fold,
2.63-fold, 8.43-fold and 12.4-fold respectively on PID 3.
These up-regulated genes are representative of acute
response of host and may help host eliminate the invad-
ing viruses. However, it is interesting to note that the
genes including Alpha-2-macroglobulin (A2M), Trans-
ferrin and Fibronectin were down-regulated on PID 3.
A2M has been identified as the inhibitor of influenza A
virus in pig serum with virus-neutralizing activity [60].
Recently, using proteomics method, researchers identi-
fied A2M in the salivary of people infected with swine
origin influenza A virus (S-OIV), and explored A2M as
a novel receptor-targeted inhibitor against S-OIV [61].
The cause and effect of down-regulated expression of
these genes associated with acute-phase response need
further study.
The expression of the immune cell markers
Cellular immune responses are critical for the complete
clearance of the influenza virus [62]. Pigs infected with
H3N2 and H1N1 viruses have an increased frequency of
neutrophils, NK cells, and CD4 and CD8 T cells in the
BAL fluid [63]. As pulmonary inflammation after influenza
virus infection often involves immune cells infiltration, it
raises the question whether the host response occurs pri-
marily in sessile lung cells or could be attributed to infil-
trating immune cells. In the current study, several genes as
immune cell markers were also detected moderately up-
regulated, containing some markers associated with mono-
cytes and macrophages (e.g. CD14, CD163) or T lympho-
cytes (e.g. CD2, CD3ε and CD8A) on PID 3 [64]. In some
cases these CD molecules do show a parallel expression
pattern, as expected if the gene expression responses are
caused by cellular influx. Recently, some researchers have
found that higher frequencies of cytotoxic T lymphocytes,
dendritic cells, activated T cells, and CD4+ and CD8+ T
cells could be detected in SwIV-infected pig lungs by flow
cytometric analysis [13]. In addition, leukocyte/endothelial
cell adhesion molecules are essential mediators of both
immune and inflammatory responses, especially impli-
cated in leukocyte recruitment, trafficking and tissue
damage [52]. In the current study, some cell adhesion
molecules were detected over-expression during the acute
virus infection, such as the families of immunoglobulin
superfamily (IGSF21), selectins (SELL, SELE), and other
molecules like CD274, CR2 and their ligands, which could
be considered as the indirect evidences for leukocyte
recruitments. Therefore, these suggested that the host
immune and inflammatory responses in our study could
be partly attributed to immune-related cells influx after
virus infection. Other functional classes of DE genes
involved in host response might be essentially dependent
on gene expression changes in sessile pulmonary cells.
Further study is suggested to be focused on the impact of
immune cells influx to transcriptional changes of lungs
after SwIV infection.
Conclusions
In this work, we compared host clinical signs and
pathology changes between infected pigs with H1N1
SwIV and the controls at the different stages, and subse-
quently determined 268 DE genes on PID 3 and 214 DE
genes on PID 7 respectively, through DNA microarray
analysis under the specific criteria. Our data explained
that a series of genes involved in host defense responses
were activated after the H1N1 SwIV invasion, which
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Page 12 of 14might be contributors to eliminating virus and severe
immunopathology associated with virus infections. The
comparison of the overall pattern of antiviral signaling
and pro-inflammatory pathways activated by SwIV, it
could help to screen the potential host agents for redu-
cing the prevalence of SwIV and further understand the
pathogenesis of swine influenza infection in pigs.
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